FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST

K Number: K033982 · Decision Jan 22, 2004
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
8
Applicant Total
9
Review Days
30

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST
K Number
K033982
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
866.6010
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Vysis
Date Received
December 23, 2003
Decision Date
January 22, 2004
Product Code
MMW
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MMW System, Test, Tumor Marker, Monitoring, Bladder

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MMW), ordered by most recent decision date.

View all

Other Clearances by Vysis

K Number Device Name
DEN040010 VYSIS AUTOVYSION SYSTEM
K013785 UROVYSION BLADDER CANCER RECURRENCE KIT
K011031 VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
K010288 ANEUVYSION MULITICOLOR DNA PROBE KIT
K972200 ANEUVYSION
K954214 CEP X SPECTRUMORANGE\Y SPECTRUMGREEN DNA PROBE KIT
K962873 CEP 12 SPECTRUMORANGE DIRECT LABELED CHROMOSOME ENUMERATION DNA PROBE
K953591 CEP 8 SPECTRUMORANGE DNA PROBE KIT